Syros Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
SYRS
CUSIP
87184Q206
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 87184Q206 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Avidity Partners Management LP 13G/A
7.6%
Checked 5% or less
2/14/2025
Event 12/31/2024
Samsara BioCapital, L.P. 13D/A
2.6% 3/27/2025
Event 11/18/2024
Adage Capital Partners GP, L.L.C. 13G/A
2.0% 2/12/2025
Event 12/31/2024
Point72 Asset Management, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 8 483 k $12.4 k
2024 Q4 52 5.23 M $1.20 M
2024 Q3 75 19.3 M $41.4 M
2024 Q2 76 20.4 M $105 M
2024 Q1 82 21.0 M $112 M
2023 Q4 65 19.5 M $149 M
2023 Q3 50 12.1 M $47.9 M
2023 Q2 56 10.6 M $33.5 M
2023 Q1 60 10.3 M $27.5 M
2022 Q4 59 10.6 M $38.0 M
2022 Q3 54 8.45 M $54.4 M